A 17.3% passive stake from a corporate investor signals strong conviction but no activist intent. Monitor for any subsequent conversion to a 13D or additional purchases that could indicate a strategic partnership or eventual control attempt.
Price Chart
Executive Summary
PharmAla Biotech Holdings Inc. disclosed a 17.3% passive stake in Jupiter Neurosciences via a Schedule 13G filed September 22, 2026, reporting 132,867 common shares. This is a new position, not an amendment, and the filer certifies no intent to influence control. The stake is large (>10%) but passive, making it a notable but neutral signal of conviction from a corporate investor.
Key Financial Metrics
Key Facts
- PharmAla Biotech Holdings Inc. filed a new Schedule 13G on 2026-09-22
- Reports beneficial ownership of 132,867 shares of Jupiter Neurosciences common stock
- Stake represents 17.3% of 770,081 outstanding shares
- Filer certifies passive intent under Rule 13d-1(c) — no control or influence purpose
- This is a new position, not an amendment to a prior filing
Financial Impact
17.3% passive stake valued at an undisclosed amount based on filing date price
Risk Factors
- PharmAla could later convert to a 13D and become activist, though no current indication
- Large concentrated ownership may reduce public float and liquidity
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000912282-26-001297 |
| Document: 0000912282-26-001297-index.html | 0000912282-26-001297 |
| Document: 0000912282-26-001297.txt | 0000912282-26-001297 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13G/A | $2.88 | awaiting T+5 | — | $2.70 (−6.25%) |
Sep 24, 2026 4w ago | S-3 | $2.67 $2.55 | ▲ +4.49% | ▲ +4.27% | $2.70 (−1.12%) |
Sep 22, 2026 5w ago | SC 13G | $2.98 $2.58 | ▼ −13.42% | ▼ −12.24% | $2.70 (−9.40%) |
Aug 28, 2026 8w ago | 8-K | $3.54 $3.08 | ▲ +12.99% | ▲ +12.85% | $2.70 (+23.73%) |
Aug 27, 2026 8w ago | 8-K | $4.89 $3.26 | ▲ +33.33% | ▲ +33.60% | $2.70 (+44.79%) |
Aug 24, 2026 9w ago | 8-K | $5.17 $3.35 | ▲ +35.20% | ▲ +34.66% | $2.70 (+47.78%) |
Aug 24, 2026 9w ago | 8-K | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.70 (+52.30%) |
Aug 24, 2026 9w ago | 424B5 | $5.66 $3.54 | ▲ +37.46% | ▲ +37.92% | $2.70 (+52.30%) |
Jul 27, 2026 13w ago | 8-K | $0.1135 $0.1000 | ▲ +11.89% | ▲ +14.41% | $2.70 (−2278.85%) |
Jul 21, 2026 14w ago | Press Release | $0.1697 $0.1097 | ▼ −35.36% | ▼ −34.36% | $2.70 (+1491.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers